(Q35041919)

English

Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

0 references

1 reference

Europe PubMed Central

Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6984628&resulttype=core&format=json

14 May 2020

author name string

E H Walters

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6984628&resulttype=core&format=json

14 May 2020

J A Walters

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6984628&resulttype=core&format=json

14 May 2020

P W Gibson

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6984628&resulttype=core&format=json

14 May 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Cochrane Database of Systematic Reviews

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6984628&resulttype=core&format=json

14 May 2020

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6984628&resulttype=core&format=json

14 May 2020

CD003901

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6984628&resulttype=core&format=json

14 May 2020

Comparison of asthma prevalence in the ISAAC and the ECRHS. ISAAC Steering Committee and the European Community Respiratory Health Survey. International Study of Asthma and Allergies in Childhood

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of inhaled salmeterol on sulfur dioxide-induced bronchoconstriction in asthmatic subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacologic and clinical properties of Oxis (formoterol) Turbuhaler

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Discriminative aspects of two generic and two asthma-specific instruments: relation with symptoms, bronchodilator use and lung function in patients with mild asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salmeterol, a new inhaled beta 2-adrenergic agonist, has a longer blocking effect than albuterol on hyperventilation-induced bronchoconstriction

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis in clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of an increase in inhaled allergen dose after rimiterol hydrobromide on the occurrence and magnitude of the late asthmatic response and the associated change in nonspecific bronchial responsiveness

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and duration of salmeterol powder inhalation in protecting against exercise-induced bronchoconstriction

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Continuous eformoterol and beta 2-receptor responsiveness

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional antagonism: tolerance produced by inhaled beta 2 agonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy, safety, and effects on quality of life of salmeterol versus albuterol in patients with mild to moderate persistent asthma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of long-term salmeterol treatment on exercise-induced asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Asthma mortality: comparison between New Zealand and England

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regular inhaled salbutamol and airway responsiveness to allergen

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Results of 30 days and 12 months treatment with salmeterol in patients with asthma and COPD]

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolonged Protection against Methacholine-induced Bronchoconstriction by the Inhaled β2-Agonist Formoterol

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term cardiovascular safety of salmeterol powder pharmacotherapy in adolescent and adult patients with chronic persistent asthma: a randomized clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overnight protection by inhaled salmeterol on exercise-induced asthma in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of life during formoterol treatment: comparison between asthma-specific and generic questionnaires. Canadian and the Dutch Formoterol Investigators.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of beta-agonists and the risk of death and near death from asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Formoterol, a new long-acting bronchodilator for inhalation

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of treatment with formoterol on bronchoprotection against methacholine

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Delivering effective asthma care - how do we implement asthma guidelines?

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhaled formoterol dry powder in the treatment of patients with reversible obstructive airway disease. A 3-month, placebo-controlled comparison of the efficacy and safety of formoterol and salbutamol, followed by a 12-month trial with formoterol.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A bolus of inhaled budesonide rapidly reverses airway subsensitivity and beta2-adrenoceptor down-regulation after regular inhaled formoterol.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salmeterol: a study by prescription-event monitoring in a UK cohort of 15,407 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of salmeterol treatment on nitric oxide level in exhaled air and dose-response to terbutaline in children with mild asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A survey of current problems in meta-analysis. Discussion from the Agency for Health Care Policy and Research inter-PORT Work Group on Literature Review/Meta-Analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Global initiative for asthma (GINA) and its objectives

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Formoterol, a new long acting beta 2 agonist for inhalation twice daily, compared with salbutamol in the treatment of asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The reproducibility of the Childhood Asthma Questionnaires: measures of quality of life for children with asthma aged 4-16 years.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Addition of inhaled salmeterol to inhaled corticosteroids in patients with poorly controlled nocturnal asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long- versus short-acting beta 2-agonists. Implications for drug therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nocturnal asthma: effect of salmeterol on quality of life and clinical outcomes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term efficacy of formoterol compared to salbutamol

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salmeterol provides prolonged protection against exercise-induced bronchoconstriction in a majority of subjects with mild, stable asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and tolerance of a 12-week treatment with inhaled formoterol in patients with reversible obstructive lung disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of powder and aerosol formulations of salmeterol in the treatment of asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Formoterol, a new long-acting selective beta 2-adrenergic receptor agonist: double-blind comparison with salbutamol and placebo in children with asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Asthma exacerbations in patients taking regular salmeterol, or salbutamol for symptoms

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A six-month, placebo-controlled comparison of the safety and efficacy of salmeterol or beclomethasone for persistent asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of salmeterol on nocturnal symptoms, airway function, and inflammation in asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect on airway responsiveness of six weeks treatment with salmeterol

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salmeterol does not cause tolerance during long-term asthma therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subsensitivity to bronchoprotection against adenosine monophosphate challenge following regular once-daily formoterol

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of salmeterol in childhood asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sensitivity of quality of life domains and constructs to longitudinal change in a clinical trial comparing salmeterol with placebo in asthmatics.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of salmeterol xinafoate powder in children with chronic persistent asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interactions of glucocorticoids and beta 2-agonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A dose-response study with formoterol Turbuhaler as maintenance therapy in asthmatic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Clinical evaluation of 12 week salmeterol therapy in allergic asthma patients]

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Salmeterol improves the control of disease in patients with moderate asthma. A comparative study of inhaled salmeterol 50 mg and salbutamol depot tablets 8 mg, both administered twice daily]

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of formoterol, a long-lasting beta 2-adrenoceptor agonist, against methacholine-induced bronchoconstriction

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-acting beta 2-agonist salmeterol compared with albuterol in maintenance asthma therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bronchodilator response to salbutamol after chronic dosing with salmeterol or placebo

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An antiinflammatory effect of salmeterol, a long-acting beta(2) agonist, assessed in airway biopsies and bronchoalveolar lavage in asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The long‐acting β2‐agonist salmeterol xinafoate: effects on airway inflammation in asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhaled beclomethasone dipropionate reverts tolerance to the protective effect of salmeterol on allergen challenge

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the Bronchodilator Effect of Inhaled Short- and Long-Acting beta(2)-Agonists in Children with Bronchial Asthma: A Randomised Trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Salmeterol improves control in asthmatic patients treated in general practice. A comparative study of salmeterol (Serevent) and salbutamol (Ventoline) in patients with mild to moderate asthma]

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of exercise induced asthma by inhaled salmeterol xinafoate

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beta-agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality?

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative study of extended release albuterol sulfate and long-acting inhaled salmeterol xinafoate in the treatment of nocturnal asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Respiratory arrests in young asthmatics on salmeterol

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Asthma quality of life during 1 year of treatment with budesonide with or without formoterol.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salmeterol. A review of its pharmacological properties and clinical efficacy in the management of children with asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolonged effect of inhaled salmeterol against exercise-induced bronchospasm

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pilgrim's progress: the effect of salmeterol in older children with chronic severe asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Formoterol. An update of its pharmacological properties and therapeutic efficacy in the management of asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of subsensitivity to albuterol after treatment with salmeterol in patients with asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term effects of formoterol and salbutamol on bronchial hyperreactivity and beta-adrenoceptor density on lymphocytes in children with bronchial asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salmeterol powder compared with albuterol aerosol as maintenance therapy for asthma in adolescent and adult patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tolerance to the protective effects of salmeterol on methacholine-induced bronchoconstriction: influence of inhaled corticosteroids

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

National Asthma Education and Prevention Program working group report on the cost effectiveness of asthma care

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The duration of action of inhaled formoterol dry powder

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the effects of salmeterol and salbutamol on clinical activity and eosinophil cationic protein serum levels during the pollen season in atopic asthmatics.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-inflammatory effects of salmeterol compared with beclomethasone in eosinophilic mild exacerbations of asthma: a randomized, placebo controlled trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bronchodilator and bronchoprotective effects of salmeterol in young patients with asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 4-week comparison of salmeterol and terbutaline in adult asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacology of long-acting beta-receptor agonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhaled salmeterol and salbutamol in asthmatic patients. An evaluation of asthma symptoms and the possible development of tachyphylaxis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison between formoterol 12 microg b.i.d. and on-demand salbutamol in moderate persistent asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-acting beta(2)-agonists in childhood asthma: Don't change a winning team (yet)

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exacerbations of asthma in patients on salmeterol

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interactions between corticosteroids and beta agonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Altered cardiovascular autonomic regulation after salmeterol treatment in asthmatic children

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, 12-week, double-blind, placebo-controlled study comparing formoterol dry powder inhaler with albuterol metered-dose inhaler

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-acting inhaled beta(2)-agonist therapy in asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Do long-acting beta2-adrenergic agonists deserve a different place in guidelines for the treatment of asthma and COPD?

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mortality from asthma and bronchodilator aerosols

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 3-month comparison of formoterol with terbutaline via turbuhaler. A placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

β2-Adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma☆☆☆★★★

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Living with Asthma Questionnaire

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhaled salmeterol in the treatment of patients with moderate to severe reversible obstructive airways disease--a 3-month comparison of the efficacy and safety of twice-daily salmeterol (100 micrograms) with salmeterol (50 micrograms)

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tolerability to high doses of formoterol and terbutaline via Turbuhaler for 3 days in stable asthmatic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Airway responsiveness after a single dose of salmeterol and during four months of treatment in children with asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional antagonism with formoterol and salmeterol in asthmatic patients expressing the homozygous glycine-16 beta(2)-adrenoceptor polymorphism

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 1-year study of salmeterol powder on pulmonary function and hyperresponsiveness to methacholine

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protection against allergen-induced asthma by salmeterol

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A placebo-controlled, crossover comparison of salmeterol and salbutamol in patients with asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Formoterol, a new long-acting beta 2 agonist, inhaled twice daily, in stable asthmatic subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of prior treatment with salmeterol and formoterol on airway and systemic beta 2 responses to fenoterol

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy, safety, and impact on quality of life of salmeterol in patients with moderate persistent asthma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. The Netherlands and Canadian Formoterol Study Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic corticosteriod rapidly reverses bronchodilator subsensitivity induced by formoterol in asthmatic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Asthma treatment: inhaled beta-agonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The rising prevalence of asthma in young Melbourne adults is associated with improvement in treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of long-acting and short-acting beta-agonists on methacholine dose-response curves in asthmatics

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salmeterol protects against hyperventilation-induced bronchoconstriction over 12 hours

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potential masking effects of salmeterol on airway inflammation in asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of addition of inhaled salmeterol to the treatment of moderate-to-severe asthmatics uncontrolled on high-dose inhaled steroids. European Respiratory Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of formoterol on clinical parameters and lung functions in patients with bronchial asthma: a randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of genetic polymorphism on ex vivo and in vivo function of beta2-adrenoceptors in asthmatic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Respiratory arrests in young asthmatics on salmeterol

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of beclomethasone, salmeterol, and placebo in children with asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-acting beta 2-agonists. Role in primary care asthma treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bronchodilator subsensitivity after chronic dosing with eformoterol in patients with asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salmeterol tachyphylaxis in steroid treated asthmatic subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of long-term treatment with salmeterol on asthma control: a double blind, randomised crossover study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Are there any detrimental effects of the use of inhaled long-acting beta 2-agonists in the treatment of asthma?

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salmeterol xinafoate in children on high dose inhaled steroids

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-acting inhaled beta2-agonists in asthma therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Efficacy of and tolerance to salmeterol compared to salbutamol in patients with bronchial asthma]

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and tolerability of formoterol in elderly patients with reversible obstructive airways disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subsensitivity of bronchodilator and systemic beta 2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhaled Salmeterol and Albuterol in Asthmatic Patients Receiving High-dose Inhaled Corticosteroids

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salmeterol xinafoate in the treatment of mild to moderate asthma in primary care. UK Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salmeterol xinafoate in asthmatic patients under consideration for maintenance oral corticosteroid therapy. UK Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salmeterol compared with slow-release terbutaline in nocturnal asthma. A multicenter, randomized, double-blind, double-dummy, sequential clinical trial. French Multicenter Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The protective effect of salbutamol inhaled using different devices on methacholine bronchoconstriction

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative efficacy of salbutamol and salmeterol in exercise-induced asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The efficacy and safety of inhaled salmeterol 50 microg bd in older patients with reversible airflow obstruction

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salmeterol improves quality of life in patients with asthma requiring inhaled corticosteroids. Salmeterol Quality of Life Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in methacholine induced bronchoconstriction with the long acting beta 2 agonist salmeterol in mild to moderate asthmatic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A one-week dose-ranging study of inhaled salmeterol in children with asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The European Community Respiratory Health Survey: what are the main results so far? European Community Respiratory Health Survey II.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salmeterol reduces the need for inhaled corticosteroid in steroid-dependent asthmatics

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose formoterol Turbuhaler (Oxis) b.i.d., a 3-month placebo-controlled comparison with terbutaline (q.i.d.).

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salmeterol does not compromise the bronchodilator response to albuterol during acute episodes of asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A twelve-week comparison of salmeterol and salbutamol in the treatment of mild-to-moderate asthma: a Canadian multicenter study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-acting beta(2)-agonists in management of childhood asthma: A critical review of the literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Twelve months, treatment with inhaled salmeterol in asthmatic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustained improvement in asthma with long-term use of formoterol fumarate.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Treatment with salmeterol and quality of life in patients with asthma]

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of salmeterol with placebo in mild asthma: effect on peripheral blood phagocyte function and cytokine levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A placebo-controlled clinical trial of regular monotherapy with short-acting and long-acting beta(2)-agonists in allergic asthmatic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beta2-adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting beta2-agonist therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salmeterol for the treatment of asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salmeterol: a four week study of a long-acting beta-adrenoceptor agonist for the treatment of reversible airways disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety of salmeterol in the maintenance treatment of asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of formoterol dry powder administered for three months via a single-dose inhaler in 1,380 asthmatic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bronchodilator response to albuterol after regular formoterol and effects of acute corticosteroid administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short-term effects of budesonide, nedocromil sodium and salmeterol on bronchial hyperresponsiveness in childhood asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Formoterol as inhalation powder in the treatment of patients with reversible obstructive lung diseases. A 3-month placebo-controlled comparison of the effects of formoterol and salbutamol, followed by a 12-month period with formoterol alone].

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparative study in atopic subjects with asthma of the effects of salmeterol and salbutamol on allergen-induced bronchoconstriction, increase in airway reactivity, and increase in urinary leukotriene E4 excretion

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of salmeterol on the early- and late-phase reaction to bronchial allergen and postchallenge variation in bronchial reactivity, blood eosinophils, serum eosinophil cationic protein, and serum eosinophil protein X

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salmeterol in two different doses in the treatment of nocturnal bronchial asthma poorly controlled by other therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of eight weeks of treatment with salmeterol on bronchoalveolar lavage inflammatory indices in asthmatics

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of regular salmeterol vs 'as required' salbutamol therapy in asthmatic children

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 6-month comparison between formoterol and salmeterol in patients with reversible obstructive airways disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of two long-acting beta-agonists, oral bambuterol and inhaled salmeterol, in the treatment of moderate to severe asthmatic patients with nocturnal symptoms. The French Bambuterol Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salmeterol in paediatric asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term circadian effects of salmeterol in asthmatic children treated with inhaled corticosteroids

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association between β2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of inhaled salmeterol on methacholine responsiveness in subjects with asthma up to 12 hours

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid Onset of Tolerance to the Bronchoprotective Effect of Salmeterol

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salmeterol compared with current therapies in chronic asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Are asthma medications and management related to deaths from asthma?

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of long-acting beta2-agonists on airway inflammation in asthmatic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12519616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/14651858.CD003901

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6984628&resulttype=core&format=json

14 May 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6984628&resulttype=core&format=json

14 May 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6984628&resulttype=core&format=json

14 May 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35041919&oldid=2087472762"